BioXcel Therapeutics (BTAI) Prepaid Assets (2017 - 2026)

BioXcel Therapeutics' Prepaid Assets history runs 10 years deep, the most recent figure standing at $12.1 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 771.26% year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $12.1 million (up 771.26% YoY), while the FY2025 annual figure was $10.9 million, up 660.07% from the prior year.
• Prepaid Assets was $12.1 million for Q1 2026 at BioXcel Therapeutics, up from $10.9 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $12.1 million in Q1 2026 to a low of $934000.0 in Q3 2025.
• Historically, Prepaid Assets has averaged $3.7 million across 5 years, with a median of $2.1 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Prepaid Assets sank 79.15% in 2025, then soared 771.26% in 2026.
• A 5-year view of Prepaid Assets shows it stood at $3.8 million in 2022, then tumbled by 45.93% to $2.1 million in 2023, then sank by 30.7% to $1.4 million in 2024, then jumped by 660.07% to $10.9 million in 2025, then grew by 10.25% to $12.1 million in 2026.
• The last three Prepaid Assets figures came in at $12.1 million (Q1 2026), $10.9 million (Q4 2025), and $934000.0 (Q3 2025), per Business Quant data.